Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.

Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD.

Am Heart J. 2017 Sep;191:21-29. doi: 10.1016/j.ahj.2017.06.002. Epub 2017 Jun 9. Review.

2.

Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II.

Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD.

J Cardiovasc Electrophysiol. 2017 Nov;28(11):1345-1351. doi: 10.1111/jce.13307. Epub 2017 Aug 23.

3.

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.

Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, Cutler JA, Grimm R, Pedley C, Peterson K, Pop-Busui R, Sperl-Hillen J, Cushman WC.

Hypertension. 2016 Oct;68(4):888-95. doi: 10.1161/HYPERTENSIONAHA.116.07474. Epub 2016 Aug 8.

4.

Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.

Chen LY, Bigger JT, Hickey KT, Chen H, Lopez-Jimenez C, Banerji MA, Evans G, Fleg JL, Papademetriou V, Thomas A, Woo V, Seaquist ER, Soliman EZ.

Am J Hypertens. 2016 Nov 1;29(11):1276-1282. doi: 10.1093/ajh/hpv172.

5.

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H.

Hypertension. 2015 Dec;66(6):1123-9. doi: 10.1161/HYPERTENSIONAHA.115.06236. Epub 2015 Oct 12.

6.

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.

Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):179-86. doi: 10.1161/CIRCOUTCOMES.114.001306. Epub 2015 Feb 10.

7.

Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials.

Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD.

JACC Heart Fail. 2014 Dec;2(6):623-9. doi: 10.1016/j.jchf.2014.06.007. Epub 2014 Oct 8.

8.

A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.

Weng C, Li Y, Ryan P, Zhang Y, Liu F, Gao J, Bigger JT, Hripcsak G.

Appl Clin Inform. 2014 May 7;5(2):463-79. doi: 10.4338/ACI-2013-12-RA-0105. eCollection 2014.

9.

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD.

Am J Kidney Dis. 2014 Jul;64(1):32-9. doi: 10.1053/j.ajkd.2013.12.009. Epub 2014 Feb 8.

10.

Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders GD.

Int J Cardiol. 2014 Mar 1;172(1):253-4. doi: 10.1016/j.ijcard.2013.12.278. Epub 2014 Jan 10. No abstract available.

PMID:
24467982
11.

Using software to elicit user needs for clinical research visit scheduling.

Weng C, Boland MR, So Y, Rusanov A, Lopez C, Steinman R, Busacca L, Bakken S, Bigger JT.

AMIA Jt Summits Transl Sci Proc. 2014 Apr 7;2014:109-15. eCollection 2014.

12.

From expert-derived user needs to user-perceived ease of use and usefulness: a two-phase mixed-methods evaluation framework.

Boland MR, Rusanov A, So Y, Lopez-Jimenez C, Busacca L, Steinman RC, Bakken S, Bigger JT, Weng C.

J Biomed Inform. 2014 Dec;52:141-50. doi: 10.1016/j.jbi.2013.12.004. Epub 2013 Dec 12.

13.

Understanding facilitators and barriers to reengineering the clinical research enterprise in community-based practice settings.

Kukafka R, Allegrante JP, Khan S, Bigger JT, Johnson SB.

Contemp Clin Trials. 2013 Sep;36(1):166-74. doi: 10.1016/j.cct.2013.06.008. Epub 2013 Jun 25.

PMID:
23806363
14.

An Integrated Model for Patient Care and Clinical Trials (IMPACT) to support clinical research visit scheduling workflow for future learning health systems.

Weng C, Li Y, Berhe S, Boland MR, Gao J, Hruby GW, Steinman RC, Lopez-Jimenez C, Busacca L, Hripcsak G, Bakken S, Bigger JT.

J Biomed Inform. 2013 Aug;46(4):642-52. doi: 10.1016/j.jbi.2013.05.001. Epub 2013 May 16.

15.

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial.

Davidson KW, Bigger JT, Burg MM, Carney RM, Chaplin WF, Czajkowski S, Dornelas E, Duer-Hefele J, Frasure-Smith N, Freedland KE, Haas DC, Jaffe AS, Ladapo JA, Lespérance F, Medina V, Newman JD, Osorio GA, Parsons F, Schwartz JE, Shaffer JA, Shapiro PA, Sheps DS, Vaccarino V, Whang W, Ye S.

JAMA Intern Med. 2013 Jun 10;173(11):997-1004. doi: 10.1001/jamainternmed.2013.915.

16.

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.

Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD.

Heart Rhythm. 2013 Jun;10(6):828-35. doi: 10.1016/j.hrthm.2013.02.011. Epub 2013 Feb 13.

17.

Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.

Katritsis DG, Siontis KC, Bigger JT, Kadish AH, Steinman R, Zareba W, Siontis GC, Bardy GH, Ioannidis JP.

Heart Rhythm. 2013 Feb;10(2):200-6. doi: 10.1016/j.hrthm.2012.10.039. Epub 2012 Oct 27. Review.

PMID:
23107652
18.

Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.

Getaneh A, Light LS, Brillon DJ, Calles Escandón J, Felicetta J, Evans GW, Lopez-Jimenez CR, Cuddihy R, Bigger JT.

J Gen Intern Med. 2012 Nov;27(11):1499-505. doi: 10.1007/s11606-012-2131-4. Epub 2012 Jun 29.

19.

Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial.

Whang W, Burg MM, Carney RM, Freedland KE, Bigger JT, Catellier D, Czajkowski S, Frasure-Smith N, Haas DC, Jaffe AS, Lespérance F, Medina V, Duer-Hefele J, Osorio GA, Parsons F, Shapiro PA, Sheps DS, Vaccarino V, Davidson KW.

Contemp Clin Trials. 2012 Sep;33(5):1003-10. doi: 10.1016/j.cct.2012.05.005. Epub 2012 May 25.

20.

Using EHRs to integrate research with patient care: promises and challenges.

Weng C, Appelbaum P, Hripcsak G, Kronish I, Busacca L, Davidson KW, Bigger JT.

J Am Med Inform Assoc. 2012 Sep-Oct;19(5):684-7. doi: 10.1136/amiajnl-2012-000878. Epub 2012 Apr 29.

21.

A real-time screening alert improves patient recruitment efficiency.

Weng C, Batres C, Borda T, Weiskopf NG, Wilcox AB, Bigger JT, Davidson KW.

AMIA Annu Symp Proc. 2011;2011:1489-98. Epub 2011 Oct 22.

22.

Women, but not men, have prolonged QT interval if depressed after an acute coronary syndrome.

Whang W, Julien HM, Higginbotham L, Soto AV, Broodie N, Bigger JT, Garan H, Burg MM, Davidson KW.

Europace. 2012 Feb;14(2):267-71. doi: 10.1093/europace/eur246. Epub 2011 Jul 27.

23.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

24.
25.

The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised.

Bigger JT, Glassman AH.

Cleve Clin J Med. 2010 Jul;77 Suppl 3:S12-9. doi: 10.3949/ccjm.77.s3.03.

PMID:
20622070
26.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

27.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

28.

Cardiac autonomic control and treatment of hostility: a randomized controlled trial.

Sloan RP, Shapiro PA, Gorenstein EE, Tager FA, Monk CE, McKinley PS, Myers MM, Bagiella E, Chen I, Steinman R, Bigger JT Jr.

Psychosom Med. 2010 Jan;72(1):1-8. doi: 10.1097/PSY.0b013e3181c8a529. Epub 2009 Dec 22.

29.

Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.

Glassman AH, Bigger JT Jr, Gaffney M.

Arch Gen Psychiatry. 2009 Sep;66(9):1022-9. doi: 10.1001/archgenpsychiatry.2009.121.

PMID:
19736359
30.

Electronic screening improves efficiency in clinical trial recruitment.

Thadani SR, Weng C, Bigger JT, Ennever JF, Wajngurt D.

J Am Med Inform Assoc. 2009 Nov-Dec;16(6):869-73. doi: 10.1197/jamia.M3119. Epub 2009 Aug 28.

31.

Barriers, enablers, and incentives for research participation: a report from the Ambulatory Care Research Network (ACRN).

Bakken S, Lantigua RA, Busacca LV, Bigger JT.

J Am Board Fam Med. 2009 Jul-Aug;22(4):436-45. doi: 10.3122/jabfm.2009.04.090017.

33.

Re-engineering opportunities in clinical research using workflow analysis in community practice settings.

Khan SA, Kukafka R, Bigger JT, Johnson SB.

AMIA Annu Symp Proc. 2008 Nov 6:363-7.

34.

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.

Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association.

Circulation. 2008 Oct 21;118(17):1768-75. doi: 10.1161/CIRCULATIONAHA.108.190769. Epub 2008 Sep 29.

PMID:
18824640
35.

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.

36.

A day in the life of a clinical research coordinator: observations from community practice settings.

Khan SA, Kukafka R, Payne PR, Bigger JT, Johnson SB.

Stud Health Technol Inform. 2007;129(Pt 1):247-51.

PMID:
17911716
37.

Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

Glassman AH, Bigger JT, Gaffney M, Van Zyl LT.

Arch Gen Psychiatry. 2007 Sep;64(9):1025-31.

PMID:
17768267
38.

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.

Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.

PMID:
17599422
39.

Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.

Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R; Expert panel participating in a Duke Center for the Prevention of Sudden Cardiac Death-sponsored conference.

Am Heart J. 2007 Jun;153(6):951-9.

PMID:
17540195
40.

Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.

Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W; Expert panel participating in a Duke's Center for the Prevention of Sudden Cardiac Death conference.

Am Heart J. 2007 Jun;153(6):941-50.

PMID:
17540194
41.

Microvolt T-wave alternans: an effective approach to risk stratification in ischemic cardiomyopathy?

Bigger JT, Bloomfield DM.

Nat Clin Pract Cardiovasc Med. 2007 Jun;4(6):300-1. No abstract available.

PMID:
17471275
42.

Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives?

Glassman AH, Bigger JT Jr.

JAMA. 2007 Jan 24;297(4):411-2. No abstract available.

PMID:
17244839
43.

Modeling clinical trials workflow in community practice settings.

Khan SA, Payne PR, Johnson SB, Bigger JT, Kukafka R.

AMIA Annu Symp Proc. 2006:419-23.

44.

Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary.

Bigger JT, Kleiger RE.

Am J Cardiol. 2006 Nov 1;98(9):1291-3. Epub 2006 Sep 14. No abstract available.

PMID:
17056349
45.

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.

Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, Czajkowski SM, Frank E, Frasure-Smith N, Freedland KE, Froelicher ES, Glassman AH, Katon WJ, Kaufmann PG, Kessler RC, Kraemer HC, Krishnan KR, Lespérance F, Rieckmann N, Sheps DS, Suls JM; National Heart, Lung, and Blood Institute Working Group.

Psychosom Med. 2006 Sep-Oct;68(5):645-50.

PMID:
17012516
46.

"Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.

Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT Jr.

J Am Coll Cardiol. 2006 Oct 3;48(7):1399-404. Epub 2006 Sep 12.

47.

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report.

Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, Czajkowski SM, Frank E, Frasure-Smith N, Freedland KE, Froelicher ES, Glassman AH, Katon WJ, Kaufmann PG, Kessler RC, Kraemer HC, Krishnan KR, Lespérance F, Rieckmann N, Sheps DS, Suls JM.

Ann Behav Med. 2006 Oct;32(2):121-6. No abstract available.

PMID:
16972809
48.

Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.

49.
50.

Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.

Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM.

J Am Coll Cardiol. 2006 Jan 17;47(2):456-63. Epub 2005 Dec 15.

Supplemental Content

Loading ...
Support Center